DermBiont Presents Positive Phase 2 Trial Data Treating Seborrheic Keratosis
DermBiont, Inc., a Massachusetts-based corporation developing a skin microbiome therapeutics platform to treat and prevent
Via acquires Citymapper
Via Transportation Inc., a New York-based public transit company that provides on-demand public mobility solutions